Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Co-Diagnostics Logo
Co-Diagnostics Growth Score
94
CB Rank
10322
Heat Score
76
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Founded
obfuscation
PublicPost-IPO Equity Salt Lake City, Utah, United States101-250 www.codiagnostics.com
Biopharma
Biotechnology
Health Care
Life Science
Overview

Co-Diagnostics
Total Funding
obfuscation
Growth Score
94
Heat Score
76

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score94
-2 pts
in past quarter
Heat Score 76
28 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Co-Diagnostics

CB Rank
10322
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Founded
obfuscation
PublicPost-IPO Equity Salt Lake City, Utah, United States101-250 www.codiagnostics.com
Biopharma
Biotechnology
Health Care
Life Science

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name CO-DIAGNOSTICS, INC.
Operating Status Active
Stock Symbol  NASDAQ:CODX
Company Type For Profit
Founders  Brent Satterfield
About the Company

Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design

specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Phone Number (801)-438-1036
Contact Email info@codiagnostics.com
Predictions & Insights

Growth Insight

See this Growth Insight
Co-Diagnostics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Molecular Diagnostic Tests
Tests designed to detect specific genetic material from pathogens or other targets using molecular biology techniques.
Molecular Diagnostic Test Enhancement Services
Services that improve the output and accuracy of molecular diagnostic tests through optimized assay design and analysis.

Research & Development

Co-Diagnostics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Maxim Group Logo
Maxim Group
Yes
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
Maxim Group Logo
Maxim Group
Yes
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
Maxim Group Logo
Maxim Group
Yes
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
Maxim Group Logo
Maxim Group
Yes
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—
Maxim Group Logo
Maxim Group
Yes
Post-IPO Equity - Co-Diagnostics Logo
Post-IPO Equity - Co-Diagnostics
—

Investments

Number of Acquisitions 3

Investment Breakdown

Number of Acquisitions 3
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 5 Contacts 85

Employee Profiles

News

News and Press

News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

571

IT Spend

$11.7KThis year, Co-Diagnostics is projected to spend $11.7K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Cookie Deprecation Logo
Cookie Deprecation
100
TheStreet Logo
TheStreet
90
Student Retention/Remediation in Higher Education Logo
Student Retention/Remediation in Higher Education
86

Actively Used Products

20Co-Diagnostics uses 20 technology products and services including HTML5, Office 365, and  Microsoft Outlook, according to G2 Stack.

Active Website Tech Count

19Co-Diagnostics is actively using 19 technologies for its website, according to BuiltWith. These include Euro, LetsEncrypt, and  Cloudflare CDN.
Sub-Organizations
Frequently Asked Questions

Where is Co-Diagnostics's headquarters? Co-Diagnostics is located in Salt Lake City, Utah, United States.Who invested in Co-Diagnostics? Co-Diagnostics has 3 investors including Maxim Group and  Bill & Melinda Gates Foundation.When was the last funding round for Co-Diagnostics? Co-Diagnostics closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Co-Diagnostics raised to date? Co-Diagnostics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|